Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ramadan

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-AnalysisHelal F Hetta, Ayman Salama, Turki A Aljuaid, et al.
Frontiers in Public Health|December 16, 2020
Prevalence of Workaholism Among Egyptian Healthcare Workers With Assessment of Its Relation to Quality of Life, Mental Health and BurnoutZeinab A Kasemy, Eman E Abd-Ellatif, Asmaa A Abdel Latif, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Is Anlotinib and Radiotherapy Combination Effective for Non-Small-Cell Lung Cancer with Brain Metastases? A Systematic Scoping Review and Meta-AnalysisHelal F Hetta, Mostafa A Sayed Ali, Saleh F Alqifari, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Pharmaceuticals (Basel, Switzerland)|March 28, 2026
Is Brukinsa (Zanubrutinib) a Safer Bruton's Tyrosine Kinase (BTK) Inhibitor in Relapsed or Refractory Chronic Lymphocytic Leukemia? A Systematic Review and Meta-AnalysisHelal F Hetta, Ayman Salama, Turki A Aljuaid, et al.
Frontiers in Public Health|December 16, 2020
Prevalence of Workaholism Among Egyptian Healthcare Workers With Assessment of Its Relation to Quality of Life, Mental Health and BurnoutZeinab A Kasemy, Eman E Abd-Ellatif, Asmaa A Abdel Latif, et al.
Pharmaceuticals (Basel, Switzerland)|July 30, 2025
Is Anlotinib and Radiotherapy Combination Effective for Non-Small-Cell Lung Cancer with Brain Metastases? A Systematic Scoping Review and Meta-AnalysisHelal F Hetta, Mostafa A Sayed Ali, Saleh F Alqifari, et al.
Pageof 6